Ascelia Pharma AB (CHIX:ACES) FCF Yield %: -17.33 (As of Jun. 27, 2026)


CHIX:ACES Ascelia Pharma AB CHIX:ACES
28 GF Score
Price kr3.29
! 1 Warning Sign
View Full Analysis

What is Ascelia Pharma AB FCF Yield %?

Ascelia Pharma AB CHIX:ACES 28 FCF Yield % is -17.33 as of Jun. 27, 2026. GuruFocus rates CHIX:ACES with a GF Score™ of 28/100. The stock has 1 warning sign investors should review. Among 1,418 Biotechnology companies, Ascelia Pharma AB ranks worse than 63.96% on this metric.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Ascelia Pharma AB's Trailing 12-Month Free Cash Flow is kr-71.25 Mil, and Market Cap is kr411.29 Mil. Therefore, Ascelia Pharma AB's FCF Yield % for today is -17.33%.

The historical rank and industry rank for Ascelia Pharma AB's FCF Yield % or its related term are showing as below:

CHIX:ACEs' s FCF Yield % Range Over the Past 10 Years
Min: -17.79   Med: 0   Max: 0
Current: -17.33


CHIX:ACEs's FCF Yield % is ranked worse than
63.96% of 1418 companies
in the Biotechnology industry
Industry Median: -9.715 vs CHIX:ACEs: -17.33

Ascelia Pharma AB's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.


Ascelia Pharma AB FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Ascelia Pharma AB FCF Yield % Related Terms


Ascelia Pharma AB FCF Yield % Historical Data

* Premium members only.

The historical data trend for Ascelia Pharma AB's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ascelia Pharma AB FCF Yield % Chart

Ascelia Pharma AB Annual Data
Trend Jun17 Jun18 Jun19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Yield %
Get a 7-Day Free Trial Premium Member Only -5.32 -5.72 -5.77 -1.45 -1.27

Ascelia Pharma AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.56 -1.38 -1.10 -1.52 -1.11

CHIX:ACES vs VRTX, REGN, ALNY: FCF Yield % Comparison

For the Biotechnology subindustry, Ascelia Pharma AB's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ascelia Pharma AB FCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ascelia Pharma AB's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Ascelia Pharma AB's FCF Yield % falls into.


CHIX:ACES
28GF Score
Ascelia Pharma AB CHIX:ACES
FCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ascelia Pharma AB FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Ascelia Pharma AB's FCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-72.309 / 5715.44845
=-1.27%

Ascelia Pharma AB's annualized FCF Yield % for the quarter that ended in Mar. 2026 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-15.858 * 4 / 5715.44845
=-1.11%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of -17.33 mean?
Ascelia Pharma AB (CHIX:ACES) has a FCF Yield % of -17.33 as of Jun. 27, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Ascelia Pharma AB and its competitors. According to the industry distribution chart, Ascelia Pharma AB ranks #907 out of 1418 companies in the Biotechnology industry, placing it in the top 64%.
Is Ascelia Pharma AB's FCF Yield % too high?
Ascelia Pharma AB's current FCF Yield % is -17.33. Based on the distribution chart, Ascelia Pharma AB ranks #907 out of 1418 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Ascelia Pharma AB has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Ascelia Pharma AB's FCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Ascelia Pharma AB ranks #907 out of 1418 companies for FCF Yield %. This places Ascelia Pharma AB in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Ascelia Pharma AB and its competitors. Ascelia Pharma AB's current FCF Yield % is -17.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ascelia Pharma AB stock overvalued right now?
Ascelia Pharma AB (CHIX:ACES) has a current FCF Yield % of -17.33. The current FCF Yield % is -17.33. Ascelia Pharma AB's overall GF Score™ is 28/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Ascelia Pharma AB (CHIX:ACES), the current FCF Yield % is -17.33 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ascelia Pharma AB Business Description

Other Exchanges ACE:Sweden
Address Hyllie Boulevard 34, Malmo, SWE, 215 32
Ascelia Pharma AB is a biotech company focused on orphan oncology treatments. The company develops and commercializes novel drugs that address unmet medical needs and have a clear development and market pathway. It has two drug candidates, Orviglance and Oncoral, in development. Orviglance (manganese chloride tetrahydrate) is an oral contrast agent for MR imaging developed to improve the detection and visualization of focal liver lesions (including liver metastases and primary tumors) in patients with impaired kidney function, and Oncoral is a novel oral irinotecan tablet in development.
28GF Score

Get the complete analysis for CHIX:ACES

FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr3.29
Price